1 / 9

Global Aminoglycosides Market Size, Growth | Industry Report, 2022

Aminoglycosides Market Analysis By Drug (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin), By Mode of Administration (Feed, Injectables (Parenteral), Intra-mammary, Topical, Oral), By Application (Veterinary, Skin, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis) And Segment Forecasts To 2022

Marsh
Download Presentation

Global Aminoglycosides Market Size, Growth | Industry Report, 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Aminoglycosides Market Analysis, Size, Growth, Share & Forecast to 2022 | Grand View Research Inc. “Aminoglycoside Market Size To Reach $1.68 Billion By 2022” Global Aminoglycoside Market is expected to reach USD 1.68 billion by 2022 growing at an estimated CAGR of 3.5% from 2015 to 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the increasing incidences of animal disease outbreaks leading to high utilization of antibiotics. However, reduction in prescription rate of aminoglycoside antibiotics due to side effects associated with usage of these drugs that include severe ototoxicity, nephrotoxicity, and neuromuscular blockade are expected to affect the market growth negatively. Furthermore, regulatory disapproval for the usage of certain aminoglycoside in regions is also anticipated to attribute for subordinate growth in this industry. Further key findings from the report suggest: Neomycin and tobramycin together contributed for over USD 600 million as revenue in this market owing to higher usage and prescription of these drugs for treatment of different bacterial infections. Neomycin finds higher usage in topical formulations for treatment of different skin infections. • Injectables accounted for the largest share of revenue amongst other routes of administration owing to higher usage for treatment of tuberculosis, MDR-TB, and XDR-TB. Use of second line anti tuberculosis drugs such as kanamycin & capreomycin by global organizations is attributive for generation of maximum revenue in this segment. • Human use for treatment of respiratory disorders accounted for largest share in applications segment owing to rise in global incidence of tuberculosis. Furthermore, other bacterial infections of respiratory • Follow Us:

  2. tract that can be treated using aminoglycoside class of antibiotics are anticipated to contribute for expected growth in this segment. Veterinary treatment is expected to boost industrial growth in the coming years owing to higher incidence of animal diseases outbreaks. However, these drugs have restrictive regulations for administration to food-producing animals as it may lead to toxic effects and resistance development on humans after consumption of animal originated food. • Asia Pacific was the largest market, accounting for over 40% of revenue in aminoglycoside industry owing to, the presence of market players in this region coupled with higher rate of tuberculosis incidences herein. • South Africa spearheaded growth in the MEA market. The presence of relatively higher demand and consumption of injectable solutions in this region because of increase in incidence rate of MDR-TB and other drug resistant infections are some regional growth drivers. • Key participants of the aminoglycoside market include Vega Pharma Ltd., Kremoint Pharma Pvt. Ltd, Xian Wison Biological Technology Co., Ltd., Jiangxi Bolai Pharmacy Co., Ltd., Medson Pharmaceuticals, Hangzhou Uniwise International Co., Ltd., Yi Chang Veterinary Medicine Factory, HuvePharma, and Medico Remedies Pvt. Ltd. • Market players are involved in the development of products with newer formulations and lesser side effects in order to treat eradicate bacterial infections that are resistant to other class of antibiotics. • Browse Details @ http://www.grandviewresearch.com/industry-analysis/aminoglycoside-market Grand View Research has segmented aminoglycoside market on the basis of product, route of administration, application, and region: Aminoglycoside Product Outlook (Market Revenue in USD Million, 2012 - 2022 ) Neomycin • Tobramycin • Gentamicin • Amikacin • Paromomycin • Streptomycin • Kanamycin • Others • Aminoglycoside Outlook, by Route of Administration (Market Revenue in USD Million, 2012 - 2022) Injectables • Follow Us:

  3. Feed • Intra-mammary • Topical • Oral • Aminoglycoside Application Outlook (Market Revenue in USD Million, 2012 - 2022) Veterinary • Skin Infection • Respiratory diseases • UTI & Pelvic Diseases • Other diseases • Aminoglycoside Regional Outlook (Revenue, USD Million, 2012 - 2022) North America • oU.S. oCanada Europe • oUK oGermany Asia Pacific • oChina oJapan Latin America • oBrazil MEA • oSouth Africa Table of Content Follow Us:

  4. Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources Chapter 2. Executive Summary Chapter 3. Industry Outlook 3.1. Market Segmentation 3.2. Market Size and Growth Prospects 3.2.1. Market Driver Analysis 3.2.2. Market Restraint Analysis 3.3. Aminoglycosides Market Dynamics 3.4. Key Opportunities Prioritized 3.5. Industry Analysis - Porter’s 3.6. Aminoglycosides Market PESTEL Analysis Chapter 4. Aminoglycosides by Product Outlook 4.1. Neomycin 4.1.1. Neomycin Market Estimates and Forecasts, 2012 - 2022 (USD Million) 4.2. Tobramycin 4.2.1. Tobramycin Market Estimates and Forecasts, 2012 - 2022 (USD Million) 4.3. Gentamicin 4.3.1. Gentamicin Market Estimates and Forecasts, 2012 - 2022 (USD Million) 4.4. Amikacin 4.4.1. Amikacin Market Estimates and Forecasts, 2012 - 2022 (USD Million) 4.5. Paromomycin 4.5.1. Paromomycin Market Estimates and Forecasts, 2012 - 2022 (USD Million) 4.6. Streptomycin 4.6.1. Streptomycin Market Estimates and Forecasts, 2012 - 2022 (USD Million) 4.7. Kanamycin 4.7.1. Kanamycin Market Estimates and Forecasts, 2012 - 2022 (USD Million) 4.8. Other Aminoglycosides 4.8.1. Other Aminoglycosides Market Estimates and Forecasts, 2012 - 2022 (USD Million) Chapter 5. Aminoglycosides Outlook, by Route of Administration 5.1. Feed 5.1.1. Feed Market Estimates and Forecasts, 2012 - 2022 (USD Million) Follow Us:

  5. 5.2. Injectables (Parenteral) 5.2.1. Injectables (Parenteral) Market Estimates and Forecasts, 2012 - 2022 (USD Million) 5.3. Intra-mammary 5.3.1. Intra-mammary Market Estimates and Forecasts, 2012 - 2022 (USD Million) 5.4. Topical 5.4.1. Topical Market Estimates and Forecasts, 2012 - 2022 (USD Million) 5.5. Oral 5.5.1. Oral Market Estimates and Forecasts, 2012 - 2022 (USD Million) Chapter 6. Aminoglycosides Outlook, by Application 6.1. Veterinary 6.1.1. Veterinary Market Estimates and Forecasts, 2012 - 2022 (USD Million) 6.2. Skin Infection 6.2.1. Skin Infection Market Estimates and Forecasts, 2012 - 2022 (USD Million) 6.3. Respiratory diseases 6.3.1. Respiratory diseases Market Estimates and Forecasts, 2012 - 2022 (USD Million) 6.4. UTI & Pelvic Diseases 6.4.1. UTI & Pelvic Diseases Market Estimates and Forecasts, 2012 - 2022 (USD Million) 6.5. Other diseases 6.5.1. Other diseases Market Estimates and Forecasts, 2012 - 2022 (USD Million) Chapter 7. Aminoglycosides Regional Outlook 7.1. Aminoglycosides Market Share By Region, 2014 & 2020 7.2. North America 7.2.1. Aminoglycosides Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.2.2. U.S. 7.2.2.1. Aminoglycosides Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million) 7.2.2.2. Aminoglycosides Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million) 7.2.2.3. Aminoglycosides Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million) 7.2.3. Canada 7.2.3.1. Aminoglycosides Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million) 7.2.3.2. Aminoglycosides Market Estimates and Forecasts, by Route of Administration, 2012 Follow Us:

  6. - 2022 (USD Million) 7.2.3.3. Aminoglycosides Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million) 7.3. Europe 7.3.1. Aminoglycosides Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.3.2. Germany 7.3.2.1. Aminoglycosides Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million) 7.3.2.2. Aminoglycosides Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million) 7.3.2.3. Aminoglycosides Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million) 7.3.3. UK 7.3.3.1. Aminoglycosides Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million) 7.3.3.2. Aminoglycosides Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million) 7.3.3.3. Aminoglycosides Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million) 7.4. Asia Pacific 7.4.1. Aminoglycosides Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.4.2. China 7.4.2.1. Aminoglycosides Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million) 7.4.2.2. Aminoglycosides Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million) 7.4.2.3. Aminoglycosides Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million) 7.4.3. Japan 7.4.3.1. Aminoglycosides Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million) 7.4.3.2. Aminoglycosides Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million) 7.4.3.3. Aminoglycosides Market Estimates and Forecasts, by Application, 2012 - 2022 Follow Us:

  7. (USD Million) 7.5. Latin America 7.5.1. Aminoglycosides Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.5.2. Brazil 7.5.2.1. Aminoglycosides Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million) 7.5.2.2. Aminoglycosides Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million) 7.5.2.3. Aminoglycosides Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million) 7.6. MEA 7.6.1. Aminoglycosides Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.6.2. South Africa 7.6.2.1. Aminoglycosides Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million) 7.6.2.2. Aminoglycosides Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million) 7.6.2.3. Aminoglycosides Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million) Chapter 8. Competitive Landscape 8.1. Vega Pharma Ltd. 8.1.1. Company Overview 8.1.2. Financial Performance 8.1.3. Product Benchmarking 8.1.4. Strategic Development 8.2. Kremoint Pharma Pvt. Ltd 8.2.1. Company Overview 8.2.2. Financial Performance 8.2.3. Product Benchmarking 8.2.4. Strategic Development 8.3. Xian Wison Biological Technology Co., Ltd. 8.3.1. Company Overview 8.3.2. Financial Performance 8.3.3. Product Benchmarking Follow Us:

  8. 8.3.4. Strategic Development 8.4. Jiangxi Bolai Pharmacy Co., Ltd. 8.4.1. Company Overview 8.4.2. Financial Performance 8.4.3. Product Benchmarking 8.4.4. Strategic Development 8.5. Medson Pharmaceuticals 8.5.1. Company Overview 8.5.2. Financial Performance 8.5.3. Product Benchmarking 8.5.4. Strategic Development 8.6. Hangzhou Uniwise International Co., Ltd. 8.6.1. Company Overview 8.6.2. Financial Performance 8.6.3. Product Benchmarking 8.6.4. Strategic Development 8.7. Yi Chang Veterinary Medicine Factory 8.7.1. Company Overview 8.7.2. Financial Performance 8.7.3. Product Benchmarking 8.7.4. Strategic Development 8.8. HuvePharma 8.8.1. Company Overview 8.8.2. Financial Performance 8.8.3. Product Benchmarking 8.8.4. Strategic Development 8.9. Medico Remedies Pvt. Ltd 8.9.1. Company Overview 8.9.2. Financial Performance 8.9.3. Product Benchmarking 8.9.4. Strategic Development 8.10. Alfasan International BV 8.10.1. Company Overview 8.10.2. Financial Performance Follow Us:

  9. 8.10.3. Product Benchmarking 8.10.4. Strategic Development About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us:

More Related